Modafinil

Category
stimulant
Routes
Oral (PO)
Half-Life (t½)
PO: 13h
Formula
C15H15NO2S
Molecular Weight
273.35 g/mol
PubChem CID
4236
Aliases
provigil

Pharmacological Mechanism

Weak DAT inhibitor (catecholamine synthesis); orexin arousal axis and histamine receptor pharmacology modulation.

Half-Life & Elimination Curve (PO: 13h)

100%50%25%12.5%0%0h0×t½13h1×t½26h2×t½39h3×t½52h4×t½65h5×t½0×t½ (0h): 100% remaining (~1.13 mg/L)1×t½ (13h): 50% remaining (~0.565 mg/L)2×t½ (26h): 25% remaining (~0.283 mg/L)3×t½ (39h): 12.5% remaining (~0.141 mg/L)4×t½ (52h): 6.3% remaining (~70.7 µg/L)5×t½ (65h): 3.1% remaining (~35.3 µg/L)
Plasma (PO)t½ Decay (13h)Effect Site (ke0)
  • 0×t½0h100% (1.13 mg/L)
  • 1×t½13h50% (0.565 mg/L)
  • 2×t½26h25% (0.283 mg/L)
  • 3×t½39h12.5% (0.141 mg/L)
  • 4×t½52h6.3% (70.7 µg/L)
  • 5×t½65h3.1% (35.3 µg/L)
Elimination t½13h (PO)
Rate Constant (ke)0.0533 h⁻¹
Time to Peak (Tmax)3.1h
Est. Peak (Cmax)1.13 mg/L
Clearance (CL)3.2 L/h
97% Washout (5×t½)65h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Interactions

Notes

Prescription-only in most jurisdictions. Slow absorption; Tmax ~2-4h. DAT (dopamine transporter) occupancy is the primary mechanism per Volkow 2009 PET data: Ki ~2 µM = ~0.55 mg/L (modafinil MW 273). Therapeutic Cmax ~3-5 mg/L gives ~85-90% DAT occupancy — clinically informative range where the Hill curve is not yet at saturation.

Chemical Structure & Identifiers

References